connecting technology to market Piotr Karkoszka From idea to - - PowerPoint PPT Presentation

“connecting technology to market”

From idea to application, From concept to innovation, From technology to market Piotr Karkoszka pkarkoszka@tech2market.pl Benoit Rivollet brivollet@tech2market.pl

Index

1

Tech2Market

Our services Our differentiators References

A consulting firm

2

+5 people experiencedteam

> Engineers and scientists of various backgrounds with a marketing and business expertise > An international pointof view > A track record of more than 50 projects > Offices in Poland(close to Krakow)

A team of experts

More than 10 experienced partners < In constant change < With a real depth of expertise <

Two complementary teams Associated networks

At the international level

• Export your innovation
• Technology InnovationInternational

In innovation and entrepreneurship

ActInSpace < Start-up Weekend <

Public policies Funding Project management Detection Technology Transfer Company creation Growth strategies Marketing of innovation Business development

Focused on innovation-centred strategies

3

Various methodologies Coaching, training programs, studies, provision of business, temporary management, etc.

Industry Government Academic structures and research

Bridging sciences, technologies and markets

4

Index

5 Tech2Market

Our services

Our differentiators References

Our services to academics and entrepreneurs

6

Offers Clients Valorisation and technology transfer (detection, analysis and promotion) Tech Transfer Offices or R&D organisms Support to business creation (business plan, prospective studies) Inventors, entrepreneurs and incubators Diversification or new product launch (opportunity studies, positioning) Small and medium enterprises or large firms Coaching and business development (new market scouting, sales, market access) Start-ups or small and medium enterprises Entrepreneurship fostering (company spinoffs, technology transfer) Medium and large companies, public bodies

Our services to the public sector

7

Offers Clients Target scouting and audits (diversification, innovation, new ventures) Public and private investors or large firms Platform creation (technology hubs, business incubators) State, technical centres and clusters Public policies (innovation, industrial base strategies) Clusters, development agencies, governments Competitive intelligence (technical, business and regulatory) Technical centres, clusters, governments Collaborative projects (definition, partnering and coaching) Clusters, technical centres, companies

Index

8 Tech2Market Our services

Our differentiators

References

> Experience and dedication to innovation > A winning trio linking technology to market in each and every mission:

• the knowledge of an expert
• the methodology of a project leader
• the skills of our team

> A team with an international background and both technical and business competencies > A real commitmentto you:

• internal and external remuneration linked to our missions’ quality
• working with transparency and in close collaboration

Our differentiators

9

Index

10 Tech2Market Our services Our differentiators

References

References for Public policy

11 Context Studies conducted Results French Government DGE

“Future of 3D printing” for material companies and French government Strategic analysis of the possible application markets, Interviews with main players of the market at different step of the value chain Write scenarios of potential development of the 3D Printing Propose recommendations to public authorities to support development

> Financial and strategic audit for a public fund of Theranexus, a unique clinical stage pharmaceutical company, which has developed a versatile proprietary technology leading to first in class products to address brain disorders (such as narcolepsia’s residual sleepiness). > Market study of several indications for Biomunex, a company discovering and developing innovative bispecific antibodies to address unmet medical needs in the treatment of cancer. > State of the art, trend and market analysis for CERMN, a research institute working on a first in class combined therapeutic agent used in Alzheimer’s disease, then identification of potential partners for co-development and technology transfer. > Market study for Novolyze, a startup developing new bacteria models for kill steps validation in food safety control and offering services dedicated to food processing industrials. > Advisory on the European collaborative funding application of a Firalis subsidiary specialized in the discovery, development and regulatory qualification of new biomarker-based diagnostics. > Market analysis for Metafora, a biotech company dedicated to developing the use of RBDs, which are ligands of nutrient transporters, as tools revealing disease induced changes in cell physiology. > Market and strategy analysis in the fields of health, environment and energy for PorphyChem, a chemical company specialized in the synthesis of chromophores and fluorophores such as porphyrins and related compounds.

References in the fields of pharmaceutical and biotechnology products

> Opportunity study and market analysis for the Stimflex project, a CEA spin-off entrepreneurial endeavor aiming at developing and selling a transcutaneous electrical nerve stimulation system. > Financial and strategic audit for a public fund of Cardiawave, a startup dedicated to the development of an ultrasound therapeutic medical device for cardiac valve pathology. > Market and competitive analysis for Wandercraft, a company with the vision of developing an exoskeleton, intuitive and easy to use, for patient with mobility problems due to myopathies, paraplegia or ageing. > Market study and analysis of communicating medical device reimbursements systems across Europe for Orange Healthcare, enabling the company to better assist its clients. > Technico-financial feasibility study and international market analysis for a startup project at the Busi incubator, developing an innovative device for minimally invasive mitral valve annuloplasty. > Strategic market access analysis and international opportunity evaluation for Dixi Medical, a company manufacturing a stereo-electro-encephalography device for epilepsy care. > Opportunity study for an electromagnetic actuator technology developed at CNES to non- space applications such as in vitro diagnostic.

References in the fields of medical devices and e-health

> Market and trend analysis of the pharmaceutical industry in France, the USA, China , Germany and Japan for the Ministry of Economy, Finance and Industry with UbiFrance and Deloitte. > Structuration of collective offering and of potential business development opportunities for Biomeridies, a biotechnology and life sciences cluster in the Languedoc-Roussillon region. > Analysis of the regional industrial base and of collaborative initiatives to be initiated for the Burgundy Development Agency and the Club Santé, an initiative bridging healthcare sectors. > Market analysis for the Franche-Comté Chamber of Commerce of different medical device segments such as biochips, laboratory automation, neurology or implantable devices and benchmark with local know-how and resources to identify new development niches. > Analysis of information created, used, stored and shared by various stakeholders in the implantable medical device field for the I-care cluster to identify innovation opportunities. > Financial and strategic audit for Nexa of a research and innovation biotechnology platform

• perating high level multidisciplinary equipment offering services to companies and

laboratories. > Market analysis, need characterisation and benchmark for Genopole of a simple and safe DNA storage technology at room temperature offered by Imagene in the BIOBANQUE national project.

References in the fields of healthcare ecosystem advisory

> Creation of an entrepreneurial curriculum with Cancer Campus including marketing and strategic aspects, in order to assist teams span off public research in the field of oncology. > Training of healthcare professionals, researchers and students in the frame of the DUGBM, a university diploma by Pierre and Marie Curie University focused on technology transfer in medicine. > Training of professionals in the healthcare industry on market access strategic issues and value-based pricing under the EMAUD, a university diploma by UCBL 1 and EPHE Paris Sorbonne. > Partnership with OTT&PI, the Paris Hospital Technology Transfer Office, aimed at developing and experimenting new tools to better educate healthcare professionals on innovation, then detect and characterize new projects. > Advisement as the sole European Space Agency technology broker in France of 30 transfers and support of businesses using space technologies in other “terrestrial” markets. > Detection of projects holding valorisation potentials in science and engineering laboratories across upper Normandy for the Seinari agency. > Detection of promising projects in terms of technology transfer across engineering science, information technology and communications as well as human and social sciences research laboratories leading to the characterization for the Auvergne Region of more than 150 innovations by their level of maturity, their need for support and their valuation.

Other references in technology detection, transfer and training

> Co-founding and management of VitaDX, a startup dedicated at developing an early stage bladder cancer diagnosis tool based on research conducted at Paris-Sud University, CNRS, AP-HP and Onera > Management of Diamlite, a startup devoted to the development, the industrial production and the commercialization of innovative fluorescent diamonds as permanent markers for industrial (tracking and anti-counterfeiting) and life sciences (biological analysis and diagnosis) applications. > Management of Medap, a company focused on the development, manufacturing and commercialization of a new generation of cytology sample preparation automate. > Board membership at Optana, a startup developing a new device allowing the processing and coloration of cytological or histological samples by nebulization. > Management of Citrage, a company developing and commercializing amino-acid based preventive and therapeutic strategies in the field of degenerative diseases. > Co-founding and management of Celescreen, a startup incubated at Agoranov and developing an alternative method to toxicology screening using c.elegans worms > Co-founding and management of Investors4Life, an investment holding dedicated to tomorrow’s life sciences powerhouses with a first equity share in Kamax Innovative Systems.

Startups in which our team is directly involved

Benoit Rivollet

Founding partner +33(0)6 69 11 16 03 brivollet@tech2market.pl http://www.tech2market.pl Tech2Market Sp z.o.o - Ul Bohaterów Warszawy 7 28-100 Busko Zdrój NIP 655 -197-16-13

Pictures used in this presentation are under license from Fotolia, Shutterstock, UK Trade & Invest or Corbis